Adult T-cell leukemia: a review of epidemiological evidence
- PMID: 22973265
- PMCID: PMC3437524
- DOI: 10.3389/fmicb.2012.00322
Adult T-cell leukemia: a review of epidemiological evidence
Abstract
Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as southwestern Japan, the Caribbean islands, Central and South America, Intertropical Africa, and Middle East. To date, many epidemiological studies have been conducted to investigate the incidence of ATL among general population or HTLV-1 carriers and to identify a variety of laboratory, molecular, and host-specific markers to be possible predictive factors for developing ATL because HTLV-1 infection alone is not sufficient to develop ATL. This literature review focuses on the epidemiology of ATL and the risk factors for the development of ATL from HTLV-1 carriers, while keeping information on the epidemiology of HTLV-1 to a minimum. The main lines of epidemiological evidence are: (1) ATL occurs mostly in adults, at least 20-30 years after the HTLV-1 infection, (2) age at onset differs across geographic areas: the average age in the Central and South America (around 40 years old) is younger than that in Japan (around 60 years old), (3) ATL occurs in those infected in childhood, but seldom occurs in those infected in adulthood, (4) male carriers have about a three- to fivefold higher risk of developing ATL than female, (5) the estimated lifetime risk of developing ATL in HTLV-1 carriers is 6-7% for men and 2-3% for women in Japan, (6) a low anti-Tax reactivity, a high soluble interleukin-2 receptor level, a high anti-HTLV-1 titer, and high levels of circulating abnormal lymphocytes and white blood cell count are accepted risk factors for the development of ATL, and (7) a higher proviral load (more than 4 copies/100 peripheral blood mononuclear cells) is an independent risk factor for progression of ATL. Nevertheless, the current epidemiological evidence is insufficient to fully understand the oncogenesis of ATL. Further well-designed epidemiological studies are needed.
Keywords: ATL; HTLV-1; adult T-cell leukemia; epidemiology; human T-cell leukemia virus type I.
Figures


Similar articles
-
Epidemiology of HTLV-1 Infection and ATL in Japan: An Update.Front Microbiol. 2020 May 29;11:1124. doi: 10.3389/fmicb.2020.01124. eCollection 2020. Front Microbiol. 2020. PMID: 32547527 Free PMC article. Review.
-
Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.Int J Hematol. 2002 Aug;76 Suppl 2:240-5. doi: 10.1007/BF03165123. Int J Hematol. 2002. PMID: 12430931 Review.
-
Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).Cancer Metastasis Rev. 1988 Nov;7(3):223-41. doi: 10.1007/BF00047753. Cancer Metastasis Rev. 1988. PMID: 3067901 Review.
-
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.Blood. 2010 Aug 26;116(8):1211-9. doi: 10.1182/blood-2009-12-257410. Epub 2010 May 6. Blood. 2010. PMID: 20448111
-
Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.Blood. 1998 Nov 15;92(10):3557-61. Blood. 1998. PMID: 9808547
Cited by
-
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.Br J Haematol. 2015 Jun;169(5):672-82. doi: 10.1111/bjh.13338. Epub 2015 Mar 2. Br J Haematol. 2015. PMID: 25733162 Free PMC article. Clinical Trial.
-
Relationship between triterpenoid anticancer drug resistance, autophagy, and caspase-1 in adult T-cell leukemia.PeerJ. 2016 May 12;4:e2026. doi: 10.7717/peerj.2026. eCollection 2016. PeerJ. 2016. PMID: 27190722 Free PMC article.
-
Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.Retrovirology. 2015 Aug 12;12:71. doi: 10.1186/s12977-015-0196-y. Retrovirology. 2015. PMID: 26265053 Free PMC article.
-
Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?Int J Cancer. 2019 Apr 1;144(7):1664-1675. doi: 10.1002/ijc.31922. Epub 2018 Dec 18. Int J Cancer. 2019. PMID: 30303535 Free PMC article.
-
Mother-to-Child HTLV-1 Transmission: Unmet Research Needs.Front Microbiol. 2019 May 8;10:999. doi: 10.3389/fmicb.2019.00999. eCollection 2019. Front Microbiol. 2019. PMID: 31134031 Free PMC article. Review.
References
-
- Arisaw K., Katamine S., Kamihira S., Kurokawa K., Sawada T., Soda M., Doi H., Saito H., Shirahama S. (2002). A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan. Cancer Causes Control 13, 657–66310.1023/A:1019511224501 - DOI - PubMed
-
- Arisawa K., Soda M., Endo S., Kurokawa K., Katamine S., Shimokawa I., Koba T., Takahashi T., Saito H., Doi H., Shirahama S. (2000). Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int. J. Cancer 85, 319–32410.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B - DOI - PubMed
LinkOut - more resources
Full Text Sources